Tech Company Financing Transactions
Predicta Biosciences Funding Round
Predicta Biosciences, based in Boston, raised $5.2 million from Engine Ventures, American Cancer Society and Illumina Ventures.
Transaction Overview
Company Name
Announced On
7/16/2024
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand its team, and build a CLIA lab and workflow for sequencing and bioinformatics.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Predicta Biosciences is a precision oncology company integrating cutting-edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Our platform utilizes AI and cutting edge multi-omics technology to develop personalized treatment options for patients. We believe in empowering clinicians with the tools and knowledge they need to make informed decisions and provide the best care possible.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kate Caves
Chief Financial Officer
Joanne Bryce
Co-Founder
Ken Anderson
Co-Founder
Keith Flaherty
Co-Founder
Gad Getz
Co-Founder
Irene Ghobrial
Co-Founder
Romanos Sklavenitis-Pisto?dis
VP - R & D
Aparna Raval
Browse more venture capital transactions:
Prev: 7/16/2024: Kins venture capital transaction
Next: 7/16/2024: OCN venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs